CSK Tri-Axis Dominant-Primary Series V-PR

Mentha × piperita

Peppermint

Tier VCSK Tri-Axis Dominant-Primary Series

Target Trait

2.8×

fold-change

Cooling-dominant tri-axis S+K modulated fold-change

Technical Specifications

SKU

SS-F-M3-02248

Genomic Edits

GC Content

45.2%

Construct Length

7,037 bp

Promoter System

Ubiquitin / T7

Expression System

Protoplast PEG-fusion

Host Strain

PEG-mediated

Receptor Target

TRPM8 + TAS1R2/TAS1R3 + CaSR

IFI Score

280

Pathway Edits

TRPM8 pathway primary gene cluster for cooling (IFI-C) tri-axis component
TAS1R2/TAS1R3 pathway primary gene cluster for sweet (IFI-S) tri-axis component
CaSR pathway primary gene cluster for kokumi (IFI-K) tri-axis component
Tri-axis metabolic flux partitioning hub for concurrent CSK pathway operation
Cross-pathway regulatory circuit for cooling-dominant CSK triple-axis expression
Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPM8, TAS1R2/TAS1R3, and CaSR pathways simultaneously engineeredCooling-dominant tri-axis expression strategy (CSK) with cross-pathway flux managementPEG-mediated co-transfection of axis constructs for rapid phenotypic screening of multi-axis combinations

IFI Subscale Profile

IFI Profile

IFI-S

—

IFI-U

—

IFI-B

—

IFI-K

—

IFI-C

—

IFI-P

—

IFI-A

—

IFI-F

—

Use Case

Tier V CSK triple-axis construct for advanced multi-modal sensory architecture combining cooling, sweet, and kokumi axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$9999 · Tier V License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-M All Modalities